ÈËÆÞÖгöÊÓƵ

Journal Article

1. Alexander ME, Gongwer R, Trachtenberg FL, Minich LL, Triedman JK, Kaltman JR, Czosek RJ, Tristani-Firouzi M, LaPage MJ, Tsao SS, Radbill AE, DiLorenzo MP, Kovach JR, Stephenson EA, Janson C, Mao C, Salerno JC, Clark BC, Mahgerefteh J, Pilcher T, Johnson TR, Kim JJ, Valdes SO, Cain N, Jackson L, Saarel EV, Pediatric Heart Network Investigators (2024). Limited Relationship Between Echocardiographic Measures and Electrocardiographic Markers of Left Ventricular Size in ÈËÆÞÖгöÊÓƵy Children. Pediatr Cardiol, 45(5), 1055-1063. ()
2. Puckelwartz MJ, Pesce LL, Hernandez EJ, Webster G, Dellefave-Castillo LM, Russell MW, Geisler SS, Kearns SD, Karthik F, Etheridge SP, Monroe TO, Pottinger TD, Kannankeril PJ, Shoemaker MB, Fountain D, Roden DM, Faulkner M, MacLeod HM, Burns KM, Yandell M, Tristani-Firouzi M, George AL Jr, McNally EM (2024). The impact of damaging epilepsy and cardiac genetic variant burden in sudden death in the young. Genome Med, 16(1), 13. ()
3. Shah RA, Chahal CAA, Ranjha S, Dabbagh GS, Asatryan B, Limongelli I, Khanji M, Ricci F, De Paoli F, Zucca S, Tristani-Firouzi M, St Louis EK, So EL, Somers VK (2023). Cardiovascular Disease Burden, Mortality and Sudden Death Risk in Epilepsy -- a UK Biobank study. Can J Cardiol. ()
4. Miller TA, Hernandez EJ, Gaynor JW, Russell MW, Newburger JW, Chung W, Goldmuntz E, Cnota JF, Zyblewski SC, Mahle WT, Zak V, Ravishankar C, Kaltman JR, McCrindle BW, Clarke S, Votava-Smith JK, Graham EM, Seed M, Rudd N, Bernstein D, Lee TM, Yandell M, Tristani-Firouzi M (2023). Genetic and clinical variables act synergistically to impact neurodevelopmental outcomes in ÈËÆÞÖгöÊÓƵren with single ventricle heart disease. Commun Med (Lond), 3(1), 127. ()
5. Glotzbach JP, Hanson HA, Tonna JE, Horns JJ, McCarty Allen C, Presson AP, Griffin CL, Zak M, Sharma V, Tristani-Firouzi M, Selzman CH (2023). Familial Associations of Prevalence and Cause-Specific Mortality for Thoracic Aortic Disease and Bicuspid Aortic Valve in a Large-Population Database. Circulation, 148(8), 637-647. ()
6. Zimmerman RM, Hernandez EJ, Watkins WS, Blue N, Tristani-Firouzi M, Yandell M, Steinberg BA (2023). An Explainable Artificial Intelligence Approach for Discovering Social Determinants of ÈËÆÞÖгöÊÓƵ and Risk Interactions for Stroke in Patients With Atrial Fibrillation. Am J Cardiol, 201, 224-226. ()
7. Yu M, Aguirre M, Jia M, Gjoni K, Cordova-Palomera A, Munger C, Amgalan D, Rosa Ma X, Pereira A, Tcheandjieu C, Seidman C, Seidman J, Tristani-Firouzi M, Chung W, Goldmuntz E, Srivastava D, Loos RJF, Chami N, Cordell H, Dreen M, Mueller-Myhsok B, Lahm H, Krane M, Pollard KS, Engreitz JM, Gagliano Taliun SA, Gelb BD, Priest JR (2023). Oligogenic Architecture of Rare Noncoding Variants Distinguishes 4 Congenital Heart Disease Phenotypes. Circ Genom Precis Med, 16(3), 258-266. ()
8. Jang MY, Patel PN, Pereira AC, Willcox JAL, Haghighi A, Tai AC, Ito K, Morton SU, Gorham JM, McKean DM, DePalma SR, Bernstein D, Brueckner M, Chung WK, Giardini A, Goldmuntz E, Kaltman JR, Kim R, Newburger JW, Shen Y, Srivastava D, Tristani-Firouzi M, Gelb BD, Porter GA Jr, Seidman CE, Seidman JG (2023). Contribution of Previously Unrecognized RNA Splice-Altering Variants to Congenital Heart Disease. Circ Genom Precis Med, 16(3), 224-231. ()
9. Balderas E, Eberhardt DR, Lee S, Pleinis JM, Sommakia S, Balynas AM, Yin X, Parker MC, Maguire CT, Cho S, Szulik MW, Bakhtina A, Bia RD, Friederich MW, Locke TM, Van Hove JLK, Drakos SG, Sancak Y, Tristani-Firouzi M, Franklin S, Rodan AR, Chaudhuri D (2022). Mitochondrial calcium uniporter stabilization preserves energetic homeostasis during Complex I impairment. Nat Commun, 13(1), 2769. ()
10. Willcox JAL, Geiger JT, Morton SU, McKean D, Quiat D, Gorham JM, Tai AC, DePalma S, Bernstein D, Brueckner M, Chung WK, Giardini A, Goldmuntz E, Kaltman JR, Kim R, Newburger JW, Shen Y, Srivastava D, Tristani-Firouzi M, Gelb B, Porter GA Jr, Seidman JG, Seidman CE (2022). Neither cardiac mitochondrial DNA variation nor copy number contribute to congenital heart disease risk. Am J Hum Genet, 109(5), 961-966. ()
11. Morton SU, Pereira AC, Quiat D, Richter F, Kitaygorodsky A, Hagen J, Bernstein D, Brueckner M, Goldmuntz E, Kim RW, Lifton RP, Porter GA Jr, Tristani-Firouzi M, Chung WK, Roberts A, Gelb BD, Shen Y, Newburger JW, Seidman JG, Seidman CE (2022). Genome-Wide De Novo Variants in Congenital Heart Disease Are Not Associated With Maternal Diabetes or Obesity. Circ Genom Precis Med, 15, CIRCGEN121003500. ()
12. Nicholas TJ, Al-Sweel N, Farrell A, Mao R, Bayrak-Toydemir P, Miller CE, Bentley D, Palmquist R, Moore B, Hernandez EJ, Cormier MJ, Fredrickson E, Noble K, Rynearson S, Holt C, Karren MA, Bonkowsky JL, Tristani-Firouzi M, Yandell M, Marth G, Quinlan AR, Brunelli L, Toydemir RM, Shayota BJ, Carey JC, Boyden SE, Malone Jenkins S (2022). Comprehensive variant calling from whole-genome sequencing identifies a complex inversion that disrupts ZFPM2 in familial congenital diaphragmatic hernia. Mol Genet Genomic Med, 10(4), e1888. ()
13. Palmquist R, Jenkins SM, Bentley D, Miller C, Mao R, Meibos B, Bayrak-Toydemir P, Tvrdik T, Nadauld LD, Bleyl SB, Chowdhury S, Ostrander B, Flores-Daboub J, Longo N, Tristani-Firouzi M, Hobbs C, Bonkowsky JL, Brunelli L (2022). Evaluating use of changing technologies for rapid next-generation sequencing in pediatrics. Pediatr Res. ()
14. Wesoowski S, Lemmon G, Hernandez EJ, Henrie A, Miller TA, Weyhrauch D, Puchalski MD, Bray BE, Shah RU, Deshmukh VG, Delaney R, Yostl HJ, Eilbeck K, Tristani-Firouzi M, Yandell M (2022). An explainable artificial intelligence approach for predicting cardiovascular outcomes using electronic health records. PLOS Digit ÈËÆÞÖгöÊÓƵ, 1(1). ()
15. Hateley S, Lopez-Izquierdo A, Jou CJ, Cho S, Schraiber JG, Song S, Maguire CT, Torres N, Riedel M, Bowles NE, Arrington CB, Kennedy BJ, Etheridge SP, Lai S, Pribble C, Meyers L, Lundahl D, Byrnes J, Granka JM, Kauffman CA, Lemmon G, Boyden S, Scott Watkins W, Karren MA, Knight S, Brent Muhlestein J, Carlquist JF, Anderson JL, Chahine KG, Shah KU, Ball CA, Benjamin IJ, Yandell M, Tristani-Firouzi M (2021). The history and geographic distribution of a KCNQ1 atrial fibrillation risk allele. Nat Commun, 12(1), 6442.
16. Landstrom AP, Kim JJ, Gelb BD, Helm BM, Kannankeril PJ, Semsarian C, Sturm AC, Tristani-Firouzi M, Ware SM, American Heart Association Council on Genomic and Precision Medicine Council on Lifelong Congenital Heart Disease and Heart ÈËÆÞÖгöÊÓƵ in the Young Council on Arteriosclerosis Thrombosis and Vascular Biology and Council on Lifestyle and Cardiometabolic ÈËÆÞÖгöÊÓƵ (2021). Genetic Testing for Heritable Cardiovascular Diseases in Pediatric Patients: A Scientific Statement From the American Heart Association. Circ Genom Precis Med, 14(5), e000086. ()
17. Lemmon G, Wesolowski S, Henrie A, Tristani-Firouzi M, Yandell M (2021). A Poisson binomial-based statistical testing framework for comorbidity discovery across electronic health record datasets. Nat Comput Sci, 1(10), 694-702. ()
18. Malone Jenkins S, Palmquist R, Kapron AL, Torr C, Best DH, Karren MA, Brunelli L, Yandell M, Tristani-Firouzi M, Dimmock D, Watts B, Botkin JR, Johnson A, Bonkowsky JL (2021). Addressing ethical and laboratory challenges for initiation of a rapid whole genome sequencing program. J Clin Transl Sci, 5(1), e177. ()
19. Malone Jenkins S, Palmquist R, Kapron AL, Torr C, Best DH, Karren MA, Brunelli L, Yandell M, Tristani-Firouzi M, Dimmock D, Watts B, Botkin JR, Johnson A, Bonkowsky JL (2021). Addressing ethical and laboratory challenges for initiation of a rapid whole genome sequencing program. J Clin Transl Sci, 5(1), e177.
20. Pedersen BS, Brown JM, Dashnow H, Wallace AD, Velinder M, Tristani-Firouzi M, Schiffman JD, Tvrdik T, Mao R, Best DH, Bayrak-Toydemir P, Quinlan AR (2021). Effective variant filtering and expected candidate variant yield in studies of rare human disease. NPJ Genom Med, 6(1), 60. ()
21. Gakenheimer-Smith L, Meyers L, Lundahl D, Menon SC, Bunch TJ, Sawyer BL, Tristani-Firouzi M, Etheridge SP (2021). Expanding the phenotype of CACNA1C mutation disorders. Mol Genet Genomic Med, 9(6), e1673. ()
22. Musfee FI, Agopian AJ, Goldmuntz E, Hakonarson H, Morrow BE, Taylor DM, Tristani-Firouzi M, Watkins WS, Yandell M, Mitchell LE (2021). Common Variation in Cytoskeletal Genes is Associated with Conotruncal Heart Defects. Genes (Basel), 12(5). ()
23. Morton SU, Shimamura A, Newburger PE, Opotowsky AR, Quiat D, Pereira AC, Jin SC, Gurvitz M, Brueckner M, Chung WK, Shen Y, Bernstein D, Gelb BD, Giardini A, Goldmuntz E, Kim RW, Lifton RP, Porter GA Jr, Srivastava D, Tristani-Firouzi M, Newburger JW, Seidman JG, Seidman CE (2020). Association of Damaging Variants in Genes With Increased Cancer Risk Among Patients With Congenital Heart Disease. JAMA Cardiol, 6(4), 457-462. ()
24. Martin-Trujillo A, Patel N, Richter F, Jadhav B, Garg P, Morton SU, McKean DM, DePalma SR, Goldmuntz E, Gruber D, Kim R, Newburger JW, Porter GA Jr, Giardini A, Bernstein D, Tristani-Firouzi M, Seidman JG, Seidman CE, Chung WK, Gelb BD, Sharp AJ (2020). Rare genetic variation at transcription factor binding sites modulates local DNA methylation profiles. PLoS Genet, 16(11), e1009189. ()
25. Sharma A, Wasson LK, Willcox JA, Morton SU, Gorham JM, DeLaughter DM, Neyazi M, Schmid M, Agarwal R, Jang MY, Toepfer CN, Ward T, Kim Y, Pereira AC, DePalma SR, Tai A, Kim S, Conner D, Bernstein D, Gelb BD, Chung WK, Goldmuntz E, Porter G, Tristani-Firouzi M, Srivastava D, Seidman JG, Seidman CE, Pediatric Cardiac Genomics Consortium (2020). GATA6 mutations in hiPSCs inform mechanisms for maldevelopment of the heart, pancreas, and diaphragm. Elife, 9. ()
26. Shah RU, Mutharasan RK, Ahmad FS, Rosenblatt AG, Gay HC, Steinberg BA, Yandell M, Tristani-Firouzi M, Klewer J, Mukherjee R, Lloyd-Jones DM (2020). Development of a Portable Tool to Identify Patients With Atrial Fibrillation Using Clinical Notes From the Electronic Medical Record. Circ Cardiovasc Qual Outcomes, 13(10), e006516. ()
27. Richter F, Morton SU, Kim SW, Kitaygorodsky A, Wasson LK, Chen KM, Zhou J, Qi H, Patel N, DePalma SR, Parfenov M, Homsy J, Gorham JM, Manheimer KB, Velinder M, Farrell A, Marth G, Schadt EE, Kaltman JR, Newburger JW, Giardini A, Goldmuntz E, Brueckner M, Kim R, Porter GA Jr, Bernstein D, Chung WK, Srivastava D, Tristani-Firouzi M, Troyanskaya OG, Dickel DE, Shen Y, Seidman JG, Seidman CE, Gelb BD (2020). Genomic analyses implicate noncoding de novo variants in congenital heart disease. Nat Genet, 52(8), 769-777. ()
28. Boskovski MT, Homsy J, Nathan M, Sleeper LA, Morton S, Manheimer KB, Tai A, Gorham J, Lewis M, Swartz M, Alfieris GM, Bacha EA, Karimi M, Meyer D, Nguyen K, Bernstein D, Romano-Adesman A, Porter GA Jr, Goldmuntz E, Chung WK, Srivastava D, Kaltman JR, Tristani-Firouzi M, Lifton R, Roberts AE, Gaynor JW, Gelb BD, Kim R, Seidman JG, Brueckner M, Mayer JE Jr, Newburger JW, Seidman CE (2020). De Novo Damaging Variants, Clinical Phenotypes, and Post-Operative Outcomes in Congenital Heart Disease. Circ Genom Precis Med, 13(4), e002836. ()
29. Lpez-Serrano AL, De Jess-Prez JJ, Zamora-Crdenas R, Ferrer T, Rodrguez-Menchaca AA, Tristani-Firouzi M, Moreno-Galindo EG, Navarro-Polanco RA (2020). Voltage-induced structural modifications on M2 muscarinic receptor and their functional implications when interacting with the superagonist iperoxo. Biochem Pharmacol, 177, 113961. ()
30. Hsieh A, Morton SU, Willcox JAL, Gorham JM, Tai AC, Qi H, DePalma S, McKean D, Griffin E, Manheimer KB, Bernstein D, Kim RW, Newburger JW, Porter GA Jr, Srivastava D, Tristani-Firouzi M, Brueckner M, Lifton RP, Goldmuntz E, Gelb BD, Chung WK, Seidman CE, Seidman JG, Shen Y (2020). EM-mosaic detects mosaic point mutations that contribute to congenital heart disease. Genome Med, 12(1), 42. ()
31. Edwards JJ, Rouillard AD, Fernandez NF, Wang Z, Lachmann A, Shankaran SS, Bisgrove BW, Demarest B, Turan N, Srivastava D, Bernstein D, Deanfield J, Giardini A, Porter G, Kim R, Roberts AE, Newburger JW, Goldmuntz E, Brueckner M, Lifton RP, Seidman CE, Chung WK, Tristani-Firouzi M, Yost HJ, Maayan A, Gelb BD (2020). Systems Analysis Implicates WAVE2 Complex in the Pathogenesis of Developmental Left-Sided Obstructive Heart Defects. JACC Basic Transl Sci, 5(4), 376-386. ()
32. Bayrak CS, Zhang P, Tristani-Firouzi M, Gelb BD, Itan Y (2020). De novo variants in exomes of congenital heart disease patients identify risk genes and pathways. Genet Med, In Press.
33. Watkins WS, Hernandez EJ, Wesolowski S, Bisgrove BW, Sunderland RT, Lin E, Lemmon G, Demarest BL, Miller TA, Bernstein D, Brueckner M, Chung WK, Gelb BD, Goldmuntz E, Newburger JW, Seidman CE, Shen Y, Yost HJ, Yandell M, Tristani-Firouzi M (2019). De novo and recessive forms of congenital heart disease have distinct genetic and phenotypic landscapes. Nat Commun, 10(1), 4722. ()
34. Pepin ME, Drakos S, Ha CM, Tristani-Firouzi M, Selzman CH, Fang JC, Wende AR, Wever-Pinzon O (2019). DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure. Am J Physiol Heart Circ Physiol, 317(4), H674-H684. ()
35. Serrano MLA, Demarest BL, Tone-Pah-Hote T, Tristani-Firouzi M, Yost HJ (2019). Inhibition of Notch signaling rescues cardiovascular development in Kabuki Syndrome. PLoS Biol, 17(9), e3000087. ()
36. Salazar-Fajardo PD, Archiga-Figueroa IA, Lpez-Serrano AL, Rodriguez-Elias JC, Alamilla J, Snchez-Chapula JA, Tristani-Firouzi M, Navarro-Polanco RA, Moreno-Galindo EG (2018). The voltage-sensitive cardiac M2 muscarinic receptor modulates the inward rectification of the G protein-coupled, ACh-gated K+ current. Pflugers Arch, 470(12), 1765-1776. ()
37. Moss R, Sachse FB, Moreno-Galindo EG, Navarro-Polanco RA, Tristani-Firouzi M, Seemann G (2018). Modeling effects of voltage dependent properties of the cardiac muscarinic receptor on human sinus node function. PLoS Comput Biol, 14(10), e1006438. ()
38. Saarel EV, Granger S, Kaltman JR, Minich LL, Tristani-Firouzi M, Kim JJ, Ash K, Tsao SS, Berul CI, Stephenson EA, Gamboa DG, Trachtenberg F, Fischbach P, Vetter VL, Czosek RJ, Johnson TR, Salerno JC, Cain NB, Pass RH, Zeltser I, Silver ES, Kovach JR, Alexander ME, Pediatric Heart Network Investigators (2017). Electrocardiograms in ÈËÆÞÖгöÊÓƵy North American Children in the Digital Age. Circ Arrhythm Electrophysiol, 11(7), e005808. ()
39. Skarsfeldt MA, Bomholtz SH, Lundegaard PR, Lopez-Izquierdo A, Tristani-Firouzi M, Bentzen BH (2018). Atrium-specific ion channels in the zebrafish-A role of IKACh in atrial repolarization. Acta Physiol (Oxf), 223(3), e13049. ()
40. Villatoro-Gmez K, Pacheco-Rojas DO, Moreno-Galindo EG, Navarro-Polanco RA, Tristani-Firouzi M, Gazgalis D, Cui M, Snchez-Chapula JA, Ferrer T (2018). Molecular determinants of Kv7.1/KCNE1 channel inhibition by amitriptyline. Biochem Pharmacol, 152, 264-271. ()
41. Manheimer KB, Patel N, Richter F, Gorham J, Tai AC, Homsy J, Boskovski MT, Parfenov M, Goldmuntz E, Chung WK, Brueckner M, Tristani-Firouzi M, Srivastava D, Seidman JG, Seidman CE, Gelb BD, Sharp AJ (2018). Robust identification of deletions in exome and genome sequence data based on clustering of Mendelian errors. Hum Mutat, 39(6), 870-881. ()
42. Jin SC, Homsy J, Zaidi S, Lu Q, Morton S, DePalma SR, Zeng X, Qi H, Chang W, Sierant MC, Hung WC, Haider S, Zhang J, Knight J, Bjornson RD, Castaldi C, Tikhonoa IR, Bilguvar K, Mane SM, Sanders SJ, Mital S, Russell MW, Gaynor JW, Deanfield J, Giardini A, Porter GA Jr, Srivastava D, Lo CW, Shen Y, Watkins WS, Yandell M, Yost HJ, Tristani-Firouzi M, Newburger JW, Roberts AE, Kim R, Zhao H, Kaltman JR, Goldmuntz E, Chung WK, Seidman JG, Gelb BD, Seidman CE, Lifton RP, Brueckner M (2017). Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nat Genet, 49(11), 1593-1601. ()
43. Ramroop R, Manase G, Lu D, Manase D, Chen S, Kim R, Lee T, Mahle WT, McHugh K, Mitchell M, Tristani-Firouzi M, Wechsler SB, Wilder NS, Zak V, Lafreniere-Roula M, Newburger JW, Gaynor JW, Russell MW, Mital S (2017). Adrenergic receptor genotypes influence postoperative outcomes in infants in the Single-Ventricle Reconstruction Trial. J Thorac Cardiovasc Surg, 154(5), 1703-1710.e3. ()
44. Shankaran SS, Dahlem TJ, Bisgrove BW, Yost HJ, Tristani-Firouzi M (2017). CRISPR/Cas9-Directed Gene Editing for the Generation of Loss-of-Function Mutants in High-Throughput Zebrafish F0 Screens. Curr Protoc Mol Biol, 119, 31.9.1-31.9.22. ()
45. Seidel T, Navankasattusas S, Ahmad A, Diakos NA, Xu WD, Tristani-Firouzi M, Bonios MJ, Taleb I, Li DY, Selzman CH, Drakos SG, Sachse FB (2017). Sheet-Like Remodeling of the Transverse Tubular System in Human Heart Failure Impairs Excitation-Contraction Coupling and Functional Recovery by Mechanical Unloading. Circulation, 135(17), 1632-1645. ()
46. Mitzelfelt KA, McDermott-Roe C, Grzybowski MN, Marquez M, Kuo CT, Riedel M, Lai S, Choi MJ, Kolander KD, Helbling D, Dimmock DP, Battle MA, Jou CJ, Tristani-Firouzi M, Verbsky JW, Benjamin IJ, Geurts AM (2017). Efficient Precision Genome Editing in iPSCs via Genetic Co-targeting with Selection. Stem Cell Reports, 8(3), 491-499. ()
47. Jou CJ, Arrington CB, Barnett S, Shen J, Cho S, Sheng X, McCullagh PC, Bowles NE, Pribble CM, Saarel EV, Pilcher TA, Etheridge SP, Tristani-Firouzi M (2017). A Functional Assay for Sick Sinus Syndrome Genetic Variants. Cell Physiol Biochem, 42(5), 2021-2029. ()
48. Moreno-Galindo EG, Sanchez-Chapula JA, Tristani-Firouzi M, Navarro-Polanco RA (2016). Pharmacological Conversion of a Cardiac Inward Rectifier into an Outward Rectifier Potassium Channel. Mol Pharmacol, 90(3), 334-40. ()
49. Moreno-Galindo EG, Alamilla J, Sanchez-Chapula JA, Tristani-Firouzi M, Navarro-Polanco RA (2016). The agonist-specific voltage dependence of M2 muscarinic receptors modulates the deactivation of the acetylcholine-gated K(+) current (I KACh). Pflugers Arch, 468(7), 1207-1214. ()
50. Bowles NE, Jou CJ, Arrington CB, Kennedy BJ, Earl A, Matsunami N, Meyers LL, Etheridge SP, Saarel EV, Bleyl SB, Yost HJ, Yandell M, Leppert MF, Tristani-Firouzi M, Gruber PJ, Baylor Hopkins Centers for Mendelian Genomics (2015). Exome analysis of a family with Wolff-Parkinson-White syndrome identifies a novel disease locus. Am J Med Genet A, 167A(12), 2975-84. ()
51. Tristani-Firouzi M (2015). Revisiting the challenges of universal screening for long QT syndrome. J Electrocardiol, 48(6), 1053-7. ()
52. Lopez-Izquierdo A, Warren M, Riedel M, Cho S, Lai S, Lux RL, Spitzer KW, Benjamin IJ, Tristani-Firouzi M, Jou CJ (2014). A near-infrared fluorescent voltage-sensitive dye allows for moderate-throughput electrophysiological analyses of human induced pluripotent stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol, 307(9), H1370-7. ()
53. Ward RM, Drover DR, Hammer GB, Stemland CJ, Kern S, Tristani-Firouzi M, Lugo RA, Satterfield K, Anderson BJ (2014). The pharmacokinetics of methadone and its metabolites in neonates, infants, and ÈËÆÞÖгöÊÓƵren. Paediatr Anaesth, 24(6), 591-601. ()
54. Riedel M, Jou CJ, Lai S, Lux RL, Moreno AP, Spitzer KW, Christians E, Tristani-Firouzi M, Benjamin IJ (2014). Functional and pharmacological analysis of cardiomyocytes differentiated from human peripheral blood mononuclear-derived pluripotent stem cells. Stem Cell Reports, 3(1), 131-41. ()
55. Blaufox AD, Tristani-Firouzi M, Seslar S, Sanatani S, Trivedi B, Fischbach P, Paul T, Young ML, Tisma-Dupanovic S, Silva J, Cuneo B, Fournier A, Singh H, Tanel RE, Etheridge SP (2012). Congenital long QT 3 in the pediatric population. Am J Cardiol, 109(10), 1459-65. ()
56. Airey KJ, Etheridge SP, Tawil R, Tristani-Firouzi M (2009). Resuscitated sudden cardiac death in Andersen-Tawil syndrome. Heart Rhythm, 6(12), 1814-7. ()
57. Pellizzn OA, Kalaizich L, Ptcek LJ, Tristani-Firouzi M, Gonzalez MD (2007). Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome. J Cardiovasc Electrophysiol, 19(1), 95-7. ()
58. Rodriguez-Menchaca AA, Navarro-Polanco RA, Ferrer-Villada T, Rupp J, Tristani-Firouzi M, Sanchez-Chapula JA (2008). The structural basis of chloroquine block of the inward rectifier Kir2.1 channel. *corresponding author. Proc Natl Acad Sci U S A, 105(4), 1364-8.
59. Pellisson O, Kalaizich L, Ptacek LP, Tristani-Firouzi M, Gonzalez M (2007). Flecanide suppresses biventricular tachycardia and reverses tachycardia-induced cardiomyopathy in andersen-Tawil Syndrome. J Cardiovasc Electrophysiol, 9(3), 162-6.
60. Arnaout R, Ferrer T, Huisken J Spitzer EK, Stainier DYR, Tristani-Firouzi M, Chi NC (2007). Zebrafish embryonic lethal kcnh2 null: pathologic model for human homozygous long QT2 syndrome. *corresponding author. Proc Natl Acad Sci U S A, 104(27), 11316-21.

Review

1. Niu MC, Etheridge SP, Tristani-Firouzi M, Miyake CY (2023). Pediatric and Familial Genetic Arrhythmia Syndromes-Evaluation of Prolonged QTc-Differential Diagnosis and what You Need to Know. [Review]. Card Electrophysiol Clin, 16(2), 195-202. ()
2. Ebrahim MA, Pham TD, Niu MC, Etheridge SP, Tristani-Firouzi M, Miyake CY (2023). Pediatric and Familial Genetic Arrhythmia Syndromes: Evaluation of Bidirectional Ventricular Tachycardia-Differential Diagnosis. [Review]. Card Electrophysiol Clin, 16(2), 203-210. ()
3. Matthews E, Palace J, Ramdas S, Sansone V, Tristani-Firouzi M, Vicart S, Willis T (2023). Care Recommendations for the Investigation and Management of Children With Skeletal Muscle Channelopathies. [Review]. Pediatr Neurol, 145, 102-111. ()

Book Chapter

1. Tristani-Firouzi M, Sanguinett MC (2000). Delayed and Inward Rectifier Potassium Channels. In Zipes and Jalife (Eds.), Cardiac Electrophysiology: From Cell to Bedside (pp. 79-86). WB Saunders Company.
2. Sanguinetti MC, Tristani-Firouzi M (1999). Cardiac Delayed Rectifier K channels in Normal and Abnormal Cardiac Repolarization. In Jan L, Lazdunski M, Kurachi Y (Eds.), Current Topics in Membranes (46, pp. 85-101). Academic Press.
3. Tristani-Firouzi M, Kamamga-Sollo EIP, Sun S, Rocchini AP, Mathur A, Jyonouchi H (1995). Kawasaki Syndrome: T-Cell Receptor Variable Beta Gene Family Repertoire and Humoral Immunity in Kawasaki Syndrome. In Kato H (Ed.), Kawasaki Disease (pp. 200-205). Elsevier Science Inc.
4. Tristani-Firouzi M, Archer S (1995). Nitric Oxide: Mechanism of Action and Role in Human Pathophysiology. In Houston C, Sutton J, Coates G (Eds.), Hypoxia and the Brain (pp. 171-193). Queen City Printers.

Case Report

1. Sawyer BL, Tristani-Firouzi M, Wells LE, Vatta M, Etheridge SP (2020). Maternal mosaicism in long QT syndrome due to a pathogenic variant in KCNH2. HeartRhythm Case Rep, 7(2), 74-78. ()

Newspaper

1. Sable C, Li JS, Tristani-Firouzi M, Fagerlin A, Silver RM, Yandel M, Yost HJ, Beaton A, Dale J, Engel M, Watkins D, Spurney C, Skinner AC, Armstrong SC, Shah SH, Allen N, Davis M, Hou L, Van Horn L, Labarthe D, Lloyd-Jones D, Marino B (2023). American Heart Association's Children's Strategically Focused Research Network Experience. J Am Heart Assoc, pp. e028356. ()

Other

1. Balderas E, Eberhardt DR, Lee S, Pleinis JM, Sommakia S, Balynas AM, Yin X, Parker MC, Maguire CT, Cho S, Szulik MW, Bakhtina A, Bia RD, Friederich MW, Locke TM, Van Hove JLK, Drakos SG, Sancak Y, Tristani-Firouzi M, Franklin S, Rodan AR, Chaudhuri D (2022). Author Correction: Mitochondrial calcium uniporter stabilization preserves energetic homeostasis during Complex I impairment. Nat Commun (13(1), p. 3532). England. ()
2. Kannankeril PJ, Shoemaker MB, Fountain D, Roden DM, Yandell M, Tristani-Firouzi M, Etheridge SP, Webster G, George AL, McNally EM, MacLeod H, Burns KM (2021). Family Screening After Sudden Death in a Population-Based Study of Children. Pediatrics (149(4)). United States. ()

News

• Study Follows Human History and Migration of Disease
• Three School of Medicine Faculty Awarded the Honor of Benning Presidential Endowed Chair
• $12 Million in NIH Grants Propel Congenital Cardiovascular Disease Research at U of U ÈËÆÞÖгöÊÓƵ
• Artificial Intelligence Identifies Individuals at Risk for Heart Disease Complications

Podcasts

• When A Traditional Autopsy Fails, DNA May Have the Answer